Halozyme Therapeutics, Inc.
HALO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001159036
In the last 90 days, Halozyme Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 674 institutions reported holding it in 13F filings for Q2 2026, worth $9.62B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Halozyme Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 552
- +10 vs. Q1 2025
- Shares held
- 116.3M
- −4.07M (−3.4%) vs. Q1 2025
- Total value
- $6.05B
- −$1.63B (−21.2%) vs. Q1 2025
- New holders
- 90
- 181 more added
- Sold out
- 80
- 214 more reduced
8 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HALO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 674 | $9.62B |
| Q1 2026 | 637 | $7.79B |
| Q4 2025 | 619 | $8.29B |
| Q3 2025 | 604 | $8.75B |
| Q2 2025 | 552 | $6.05B |
| Q1 2025 | 550 | $7.72B |
| Q4 2024 | 509 | $5.86B |
| Q3 2024 | 510 | $7.17B |
| Q2 2024 | 460 | $6.40B |
| Q1 2024 | 413 | $5.03B |
| Q4 2023 | 411 | $4.62B |
| Q3 2023 | 390 | $4.71B |
| Q2 2023 | 370 | $4.45B |
| Q1 2023 | 387 | $4.77B |
| Q4 2022 | 423 | $7.35B |
| Q3 2022 | 357 | $5.21B |
| Q2 2022 | 368 | $5.65B |
| Q1 2022 | 316 | $5.12B |
| Q4 2021 | 326 | $5.21B |
| Q3 2021 | 326 | $5.29B |
| Q2 2021 | 315 | $5.89B |
| Q1 2021 | 337 | $5.53B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Halozyme Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −3,460−100.0% | Sold out |
| One Wealth Advisors, LLC | 0 | $0 | 0.00% | −3,443−100.0% | Sold out |
| Retirement Guys Formula LLC | 0 | $0 | 0.00% | −3,360−100.0% | Sold out |
| SeaCrest Wealth Management, LLC | 0 | $0 | 0.00% | −3,333−100.0% | Sold out |
| Bellecapital International Ltd. | 0 | $0 | 0.00% | −3,290−100.0% | Sold out |
| Wrapmanager Inc | 0 | $0 | 0.00% | −3,277−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −3,250−100.0% | Sold out |
| Cabot Wealth Management Inc | 0 | $0 | 0.00% | −3,245−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −3,223−100.0% | Sold out |
| FSM Wealth Advisors, LLC | 0 | $0 | 0.00% | −3,151−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −2,366−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,960−100.0% | Sold out |
| Reyes Financial Architecture, Inc. | 0 | $0 | 0.00% | −1,721−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −1,682−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −510−100.0% | Sold out |
| Ameriflex Group, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| NVWM, LLC | 0 | $0 | 0.00% | −344−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −197−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −195−100.0% | Sold out |
| City Holding Co | 0 | $0 | 0.00% | −184−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| American National Bank | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Cherry Tree Wealth Management, LLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Eastern Bank | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Provenance Wealth Advisors, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Hughes Financial Services, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| South State Corp. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Highline Wealth Partners LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Glenmede Trust Co NA | – | – | – | – | Not filed |
| Redwood Investments, LLC | – | – | – | – | Not filed |
| Credit Agricole S A | – | – | – | – | Not filed |
| Orion Portfolio Solutions, LLC | – | – | – | – | Not filed |
| Sheaff Brock Investment Advisors, LLC | – | – | – | – | Not filed |
| Callan Capital, LLC | – | – | – | – | Not filed |
| Caas Capital Management LP | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |